Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours

Journal of Pathology

Volumn 190, Issue 5, 2000, Pages 531-536

  Dei Tos, Angelo P ^a   Doglioni, Claudio ^b   Piccinin, Sara ^c   Sciot, Raf ^d   Furlanetto, Alberto ^a   Boiocchi, Mauro ^c   Dal Cin, Paola ^e   Maestro, Roberta ^c   Fletcher, Christopher D M ^e   Tallini, Giovanni ^f  

^a Regional Hospital   (Italy)

^b City Hospital   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e HARVARD MEDICAL SCHOOL   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical lipomatous tumour; Cdk4; Cell Cycle; HMGI C; Lipoma; Liposarcoma; Mdm2

Indexed keywords

CYCLIN DEPENDENT KINASE 4; GENE PRODUCT; HIGH MOBILITY GROUP PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME 12Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; DOUBLE MINUTE CHROMOSOME; FEMALE; GENE ACTIVATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOMA; MALE; MARKER CHROMOSOME; PRIORITY JOURNAL; RING CHROMOSOME; SUPERNUMERARY CHROMOSOME;

EID: 0034106241     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9896(200004)190:5<531::aid-path579>3.0.co;2-w     Document Type: Article

References (44)

1. Fletcher CDM, Soft tissue tumors. In Diagnostic Histopathology of Tumors, Fletcher CDM (ed.). Churchill Livingstone: Edinburgh, 1995; 1043-1096.
2. Evans HL, Soule EH, Winkelman RK. Atypical lipoma, atypical intramuscular lipoma, and well differentiated liposarcoma. A reappraisal of 30 cases formerly classified as well-differentiated liposarcoma. Cancer 1979; 43: 574-584.
3. Mentzel T, Fletcher CDM. Lipomatous tumors of the soft tissues: an update. Virchows Arch 1995; 427: 353-363.
4. Fletcher CDM, Akerman M, Dal Cin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. Am J Pathol 1996; 148: 623-630.
5. Rosai J, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors. Am J Surg Pathol 1995; 20: 1182-1189.
6. Dal Cin P, Kools P, Sciot R, et al. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 1993; 68: 85-90.
7. Pedeutour F, Forus A, Coindre J-M, et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999; 24: 30-41.
8. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80-86.
9. Leach FS, Tokino T, Meltzer P, et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993; 53: 2231-2234.
10. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 1993; 53: 5535-5541.
11. Ashar HR, Schoenberg Fejzo M, Tkachenko A, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57-65.
12. Meltzer P, Jankowski SA, Dal Cin P. Sandberg AA, Paz IB, Coccia MA. Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region on chromosome 12 frequently rearranged in soft tissue tumors. Cell Growth Differ 1991; 2: 495-501.
13. Kinzler KW, Bigner SH, Bigner DD, et al. Identification of an amplified, highly expressed gene in human glioma. Science 1987; 236: 70-73.
14. Aman P, Ron D, Mandhal N, et al. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 1992; 5: 278-285.
15. Su YA, Lee MM, Hunter CM, Meltzer PS. Characterization of a highly conserved gene (OS4) amplified with CDK4 in human sarcomas. Oncogene 1997; 15: 1289-1294.
16. Jankowski SA, De Jong P, Meltzer P. Genomic structure of SAS, a member of the transmembrane 4 superfamily amplified in human sarcomas. Genomics 1995; 25: 501-506.
17. Knight JC, Renwick PJ, Dal Cin P, Van den Berghe H, Fletcher CDM. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995; 55: 24-27.
18. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-1677.
19. Dei Tos AP, Doglioni C, Piccinin S, et al. CDM. Molecular abnormalities in dedifferentiated liposarcoma. J Pathol 1997; 181: 8-13.
20. Pilotti S, Della Torre G, Lavarino C, et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 1997; 181: 14-24.
21. Berner J-M, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 1996; 17: 254-259.
22. Pilotti S, Della Torre G, Lavarino C, et al. Molecular abnormalities in liposarcoma: role of mdm2 and CDK4 containing amplicons at 12q13-22. J Pathol 1998; 185: 188-190.
23. Schoenmakers EFPM, Wanchura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven W. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nature Genet 1995: 10: 436-444.
24. Elkhaloun AG, Bittner M, Hoskins K, Gemmill R, Meltzer PS. Molecular cytogenetic characterization and physical mapping of 12q13 15 amplification in human cancers. Genes Chromosomes Cancer 1996; 17: 205 214.
25. Berner J-M, Meda-Zepeda LA, Kools PF, et al. HMGI-C, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene 1997; 24: 2935-2941.
26. Marchetti A, Buttitta F, Girlando S, et al. mdm2 gene alterations and mdm2 expression in breast carcinomas. J Pathol 1995; 175: 31-38.
27. Tallini G, Dal Cin P, Rhoden K, et al. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumor: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol 1997; 151: 7-43.
28. Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdick J. Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog 1997: 19: 153-156.
29. Dolcetti R, Pelucchi S, Maestro R, Rizzo S, Pastore A, Boiocchi M. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol 1991; 248: 279-285.
30. Maestro R, Gloghini A, Doglioni C, et al. MDM2 over-expression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. Blood 1995; 85: 3239-3246.
31. Zuo L, Weger J, Yang Q. et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nature Genet 1996; 12: 97-99.
32. Piccinin S, Doglioni C, Maestro R, et al. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer 1997; 74: 26-30.
33. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature 1995; 375: 691-694.
34. Xiao ZX, Chen J, Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995; 375: 694-697.
35. Cordon-Cardo C, Latres E, Drobnjak M, et al. Molecular abnormalities of MDM2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54: 794-799.
36. Dei Tos AP, Maestro R, Doglioni C, et al. Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol 1996; 148: 1037-1045.
37. Dei Tos AP, Doglioni C, Piccinin S, Mentzel T, Boiocchi M, Fletcher CDM. Molecular aberrations of the G1 S cell cycle checkpoint in myxoid and round cell liposarcoma. Am J Pathol 1997; 151: 1531-1539.
38. Lovell-Badge R. Living with bad architecture. Nature 1995; 376: 725-726.
39. Rogalla P, Drechsler K, Frey G, et al. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996; 149: 775-779.
40. Manfioletti G, Giancotti V, Bandiera A, et al. CDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 1991; 19: 6793-6797.
41. Schoenberg Fejzo M, Ashar HR, Krauter KS, et al. Translocation breakpoints upstream of the HMGI-C gene in uterine leiomyomata suggest disregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer 1996; 17: 1-6.
42. Kazmierczak B, Rosigkeit J, Wanschura S, et al. HMGI-C rearrangments as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 1996; 12: 515-521.
43. Dal Cin P, Wanschura S, Kazmierczak B, et al. Amplification and expression of the HMGI-C gene in a benign endometrial polyp. Genes Chromosomes Cancer 1998; 22: 95-99.
44. Mandhal N, Akerman M, Aman P, et al. Duplication of chromosome segment 12q15 24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. Int J Cancer 1996; 67: 632-635.